LEADING TECHNOLOGY
Leading innovation in stem cells technology research and development and application
spearhead the development and introduction of innovative allogeneic cellular medicines.
About Us
ChironStem Inc. leverages its cutting-edge proprietary technology platform to spearhead the development and introduction of innovative allogeneic cellular medicines. Our revolutionary therapies are intricately designed to address unmet medical needs, particularly in…
Partner
We are actively seeking partners for collaboration in the following areas：
Co-Development of our Stem Cell based drug products.
Equity Investment in our corporation, or support our pivotal clinical trials.
News
- 2023-11-03
FDA Approves First Cell-Based Gene Therapy for Adult Patients with Multiple Myeloma
- 2023-11-03
FDA Approves New Treatment for Adults with Relapsed or Refractory Large-B-Cell Lymphoma